<DOC>
	<DOCNO>NCT02602301</DOCNO>
	<brief_summary>Objective : To evaluate relationship intravenous ( IV ) infusion oxytocin use either saline 0.9 % glucose 5 % &amp; neonatal Bilirubin &amp; sodium level . Study Design : A randomized case - control study . Setting : The Obstetrics Gynecology casuality department Kasr El Aini hospital ( Cairo University - Egypt )</brief_summary>
	<brief_title>The Effect Intravenous Oxytocin Infusion Using Different Diluents Neonatal Bilirubin &amp; Sodium Levels</brief_title>
	<detailed_description>This prospective randomize case-controlled study perform Obstetrics Gynecology causality Department Kasr El Aini University hospital , Cairo University , Egypt period November 2015 March 2016 . The study approve Hospital Ethical Committee . Informed consent obtain patient explanation aim study &amp; potential risk . The study support pharmacological company . 327 multigravidas singleton live healthy fetus present casuality department spontaneous onset labour &amp; give birth vaginal route enrol study . They randomize 3 group : group A include 109 woman labour augment IV infusion oxytocin use isotonic saline 0.9 % , group B include 109 woman labour augment IV infusion oxytocin use glucose 5 % &amp; group C ( control group ) 109 woman continue labour course without augmentation . Inclusion criterion include : maternal age 20 &amp; 35 year old , gestational age 37 40 week ( confirm reliable date last menstrual period 1st trimester ultrasound scan ) , vertex presentation fetus &amp; intact membrane . Women chronic pregnancy induce disease contraindication vaginal delivery ( e.g . malpresentation , contract pelvis &amp; placenta previa ) exclude . Additional exclusion criterion include rhesus ( Rh ) negative ( O ) blood group mother , prolong labour ( &gt; 12h ) , fetal distress , instrumental delivery ( forceps vacuum extraction ) , abnormal fetal growth ( IUGR macrosomia ) , non-reassuring initial fetal CTG &amp; epidural analgesia . Neonates one follow criterion exclude : Apgar score &lt; 5 &lt; 7 one minute five minute respectively , low birth weight ( &lt; 2.5 kg ) , birth trauma abnormal G6PD enzyme level . For patient , full history take follow complete physical examination &amp; obstetric ultrasound . Initial baseline CTG do confirm fetal wellbeing . Patient randomize one three group . 5 unit oxytocin place 500 cc isotonic saline 0.9 % 5 % glucose With begin active phase ( define fully effaced cervix 3-4 cm dilatation ) , investigator give patient either 5 unit oxytocin place 500 cc isotonic saline 0.9 % ( group A ) 5 % glucose ( group B ) . The rate infusion group 2.5 mIU/min oxytocin intravenous drip dose increase 2.5 mIU/ml every 20min till effective uterine contraction establishment ( define presence 3 forceful uterine contraction 10 min span ) . Amniotomy do cervical dilatation â‰¥ 6 cm spontaneous rupture membrane occur . Opioid analgesia give amniotomy ( meperidine hydrochloride 50 mg IM ) . Oral fluid intake restrict patient . Participants monitor bed together fetal wellbeing surveillance use continuous CTG monitoring . A partogram maintain throughout labour vaginal examination conduct record every 2 hour . Following fetal delivery , cord clamp within 2 minute birth Sodium initial bilirubin level measure cord . Umbilical cord blood sample ( 10 ml ) obtain placental site divide umbilical cord heparin test tube plasma separate immediately . Sodium , initial haemtocrit &amp; bilirubin level measure . All baby breastfed . Neonatal capillary blood ( obtain heel prick ) bilirubin haemtocrit concentration remeasured day 1 2 . Sodium measurement do use flame photometry bilirubin level determine use spectrophotometry . Data collect included total volume fluid &amp; total oxytocin dose administer till delivery , neonatal Apgar score birth ( 1 &amp; 5 minute ) , birth weight , cord sodium , haemtocrit &amp; bilirubin level birth neonatal plasma haemtocrit &amp; bilirubin level day 1 &amp; 2 .</detailed_description>
	<mesh_term>Hyperbilirubinemia</mesh_term>
	<mesh_term>Hyperbilirubinemia , Neonatal</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<mesh_term>Bilirubin</mesh_term>
	<criteria>maternal age 20 &amp; 35 year old , gestational age 37 40 week ( confirm reliable date last menstrual period 1st trimester ultrasound scan ) , vertex presentation fetus &amp; intact membrane Women chronic pregnancy induce disease contraindication vaginal delivery ( e.g . malpresentation , contract pelvis &amp; placenta previa ) exclude . Additional exclusion criterion include rhesus ( Rh ) negative ( O ) blood group mother , prolong labour ( &gt; 12h ) , fetal distress , instrumental delivery ( forceps vacuum extraction ) , abnormal fetal growth ( IUGR macrosomia ) , nonreassuring initial fetal CTG</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>oxytocin</keyword>
</DOC>